牛叉诊股

[{"date":"2026.11.10","stock":"-1.16","trade":"0.72","ind":"0.86"},{"date":"2026.11.09","stock":"1.33","trade":"-0.46","ind":"-0.27"},{"date":"2026.11.06","stock":"-0.05","trade":"-1.77","ind":"-2.57"},{"date":"2026.11.05","stock":"-0.81","trade":"2.29","ind":"1.19"},{"date":"2026.11.04","stock":"5.80","trade":"2.96","ind":"4.22"},{"date":"2026.11.03","stock":"-3.37","trade":"-0.88","ind":"-1.21"},{"date":"2026.11.02","stock":"-9.99","trade":"1.70","ind":"1.63"},{"date":"2026.10.30","stock":"-10.00","trade":"-1.05","ind":"-2.73"},{"date":"2026.10.29","stock":"-0.54","trade":"-1.88","ind":"-2.92"},{"date":"2026.10.28","stock":"-0.29","trade":"1.46","ind":"2.02"},{"date":"2026.10.27","stock":"-1.03","trade":"-3.85","ind":"-2.50"},{"date":"2026.10.26","stock":"0.29","trade":"0.14","ind":"-1.19"},{"date":"2026.10.23","stock":"-0.12","trade":"1.64","ind":"2.79"},{"date":"2026.10.22","stock":"-2.10","trade":"-3.34","ind":"-2.96"},{"date":"2026.10.21","stock":"-0.60","trade":"0.13","ind":"-0.82"},{"date":"2026.10.20","stock":"-1.11","trade":"1.00","ind":"-0.14"},{"date":"2026.10.19","stock":"3.07","trade":"-1.42","ind":"0.13"},{"date":"2026.10.16","stock":"-0.04","trade":"-0.03","ind":"-0.12"},{"date":"2026.10.15","stock":"-1.57","trade":"-1.39","ind":"-2.43"},{"date":"2026.10.14","stock":"2.73","trade":"-1.41","ind":"-1.97"},{"date":"2026.10.13","stock":"0.46","trade":"-0.78","ind":"-0.25"}]

华特达因,深证成指,化学制药指数

压力支撑

该股压力位为19.66元，支撑位为19.44元。

[{"text":"\u538b\u529b\u4f4d","value":"19.66","date":1794240000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"19.44","date":1794240000,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.0资金面打败了51%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金总体无进出。

更新时间：11月10日 16:51

机构今日流向(万元)	-1095.99	机构5日流向(万元)	-229.98
机构10日流向(万元)	759.90	机构20日流向(万元)	-7460.79

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量减少536.32万股，其中基金净增仓12家，主力净减仓185家，暂未发现中长期投资价值。

截止2026-06-30，共107家主力机构（基金99家，其他资管计划4家，一般法人2家，券商1家，社保基金1家），持仓量总计7945.26万股，占流通A股33.94%
其中，基金持仓与2025-12-31相比：
增仓：37家，增持 557.05万股
减仓：25家，减持 33.95万股
新出现在主力名单中：34家，持有1566.22万股
从主力名单中消失：219家，原持有2048.9万股

消息面诊股

诊断结果：5.5消息面打败了10%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	分红转增	不分配不转增	2026-08-21
一般消息	重大事项	公司股东股份解押	2026-08-12
利好	重大事项	参股拟上市公司或非上市公司金融机构	2026-06-30
一般消息	股东大会	年度股东大会	2026-04-24
利好	分红转增	10派20元(含税)	2026-04-24
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-12-31

一年消息统计

	所有消息	重大消息	非重大消息
利好	3条	0条	3条
利空	0条	0条	0条

行业面诊股

诊断结果：6.8行业面打败了73%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构对该行业关注较少，无任何评级。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑赢大盘。

[{"date":"2026.11.10","price":"0.86","value":"0.72"},{"date":"2026.11.09","price":"-0.27","value":"-0.46"},{"date":"2026.11.06","price":"-2.57","value":"-1.77"},{"date":"2026.11.05","price":"1.19","value":"2.29"},{"date":"2026.11.04","price":"4.22","value":"2.96"},{"date":"2026.11.03","price":"-1.21","value":"-0.88"},{"date":"2026.11.02","price":"1.63","value":"1.70"},{"date":"2026.10.30","price":"-2.73","value":"-1.05"},{"date":"2026.10.29","price":"-2.92","value":"-1.88"},{"date":"2026.10.28","price":"2.02","value":"1.46"},{"date":"2026.10.27","price":"-2.50","value":"-3.85"},{"date":"2026.10.26","price":"-1.19","value":"0.14"},{"date":"2026.10.23","price":"2.79","value":"1.64"},{"date":"2026.10.22","price":"-2.96","value":"-3.34"},{"date":"2026.10.21","price":"-0.82","value":"0.13"},{"date":"2026.10.20","price":"-0.14","value":"1.00"},{"date":"2026.10.19","price":"0.13","value":"-1.42"},{"date":"2026.10.16","price":"-0.12","value":"-0.03"},{"date":"2026.10.15","price":"-2.43","value":"-1.39"},{"date":"2026.10.14","price":"-1.97","value":"-1.41"},{"date":"2026.10.13","price":"-0.25","value":"-0.78"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	莱美药业	72.80%	24.53%	6.3分
2	科伦药业	17.03%	9.56%	6.8分
3	百济神州	16.99%	18.36%	6.5分
4	海正药业	14.93%	3.68%	5.7分
5	百利天恒	14.25%	0.67%	5.9分
6	昂利康	14.18%	6.69%	6.1分
7	健康元	13.82%	1.55%	6.5分
8	向日葵	11.29%	11.29%	6.2分
9	海创药业	10.60%	12.20%	5.2分
10	丽珠集团	10.14%	4.44%	7.0分
11	艾力斯	7.61%	1.42%	5.5分
12	健友股份	7.37%	4.76%	5.9分
13	迪哲医药	7.09%	12.05%	6.4分
14	威尔药业	6.80%	6.24%	6.0分
15	恒瑞医药	6.68%	-1.54%	6.1分
16	华纳药厂	6.52%	14.65%	6.0分
17	泰恩康	6.18%	1.77%	6.5分
18	海辰药业	5.00%	3.62%	5.0分
19	-	4.54%	-0.55%	分
20	京新药业	4.53%	1.35%	6.7分
21	ST天圣	4.12%	4.66%	5.6分
22	恩华药业	4.03%	0.27%	6.0分
23	ST复华	3.41%	9.90%	5.4分
24	华邦健康	3.40%	-2.15%	5.9分
25	首药控股	3.37%	6.35%	5.5分
26	兴齐眼药	3.12%	0.92%	5.5分
27	贝达药业	2.73%	3.19%	6.3分
28	华海药业	2.73%	4.97%	6.5分
29	仙琚制药	2.42%	-0.67%	5.8分
30	ST能特	2.37%	11.64%	6.0分
31	通化金马	2.22%	2.51%	6.0分
32	上海谊众	1.31%	4.20%	5.3分
33	信立泰	1.25%	0.33%	6.3分
34	共同药业	1.22%	6.05%	6.2分
35	华东医药	1.09%	-1.18%	6.3分
36	千红制药	0.79%	2.90%	6.1分
37	广生堂	0.77%	7.58%	5.7分
38	汇宇制药	0.62%	8.17%	5.1分
39	新和成	0.46%	-0.11%	5.9分
40	金石亚药	0.46%	8.13%	6.4分
41	川宁生物	0.13%	5.98%	5.8分
42	北大医药	0.00%	6.11%	6.2分
43	奥赛康	-0.16%	6.90%	6.9分
44	ST南新	-0.31%	6.03%	5.2分
45	复星医药	-0.47%	1.69%	6.2分
46	ST人福	-0.51%	2.14%	5.6分
47	亿帆医药	-0.64%	-0.43%	5.6分
48	吉贝尔	-1.85%	3.84%	5.0分
49	ST诺泰	-1.97%	6.56%	5.3分
50	海思科	-2.34%	3.99%	7.0分
51	小方制药	-2.62%	0.94%	5.1分
52	福元医药	-2.71%	-0.84%	5.3分
53	诚意药业	-2.92%	-1.48%	5.2分
54	九典制药	-2.96%	1.35%	5.3分
55	海翔药业	-3.11%	4.78%	5.7分
56	博瑞医药	-3.12%	2.07%	5.2分
57	海普瑞	-3.22%	0.00%	5.7分
58	东诚药业	-3.32%	1.55%	6.6分
59	金陵药业	-3.50%	4.79%	5.7分
60	国药现代	-3.55%	-2.04%	4.9分
61	华润双鹤	-3.69%	-2.55%	5.0分
62	司太立	-3.92%	0.12%	5.3分
63	常山药业	-4.23%	5.05%	6.1分
64	-	-4.30%	0.73%	分
65	溢多利	-4.53%	-0.38%	5.6分
66	天新药业	-4.57%	-0.69%	4.1分
67	永安药业	-5.18%	2.25%	6.5分
68	奥锐特	-5.48%	2.64%	4.8分
69	海欣股份	-5.50%	1.82%	5.7分
70	双鹭药业	-5.99%	1.77%	5.4分
71	同和药业	-6.14%	0.92%	5.6分
72	国邦医药	-6.24%	-0.06%	5.6分
73	北陆药业	-6.34%	3.44%	6.1分
74	前沿生物	-6.36%	11.56%	5.8分
75	一品红	-6.46%	4.18%	5.9分
76	辰欣药业	-6.67%	0.46%	4.7分
77	纳微科技	-6.71%	9.37%	6.0分
78	天宇股份	-6.79%	0.49%	6.2分
79	微芯生物	-6.80%	7.43%	5.2分
80	宏源药业	-7.29%	2.14%	6.0分
81	卫信康	-7.45%	0.12%	5.0分
82	盟科药业	-7.48%	6.29%	5.6分
83	翰宇药业	-7.63%	11.27%	6.5分
84	科源制药	-7.69%	8.10%	6.3分
85	凯因科技	-7.82%	2.56%	4.9分
86	力生制药	-8.08%	0.16%	5.1分
87	ST惠程	-8.24%	0.94%	5.5分
88	康芝药业	-8.30%	2.97%	5.7分
89	苑东生物	-8.56%	3.74%	5.2分
90	立方制药	-8.59%	2.98%	6.0分
91	福安药业	-8.79%	-1.36%	5.1分
92	-	-8.80%	3.15%	分
93	海南海药	-8.89%	3.02%	5.8分
94	东北制药	-8.90%	-0.23%	5.3分
95	尔康制药	-8.98%	1.03%	5.6分
96	亚太药业	-9.00%	5.92%	5.7分
97	花园生物	-9.04%	3.51%	5.8分
98	新华制药	-9.19%	1.36%	5.7分
99	德展健康	-9.29%	-2.01%	4.4分
100	舒泰神	-9.44%	7.17%	5.8分
101	泽璟制药	-9.49%	7.20%	5.4分
102	鲁抗医药	-9.58%	0.57%	4.7分
103	悦康药业	-9.80%	8.01%	4.7分
104	-	-9.80%	5.34%	分
105	石药景峰	-10.33%	-1.14%	5.6分
106	山河药辅	-10.42%	3.22%	5.7分
107	海森药业	-10.44%	-1.92%	5.1分
108	易明医药	-10.48%	4.20%	5.4分
109	浙江医药	-10.50%	-0.55%	4.8分
110	本立科技	-10.67%	2.79%	5.6分
111	复旦张江	-10.68%	3.49%	4.6分
112	-	-10.68%	1.07%	分
113	丰原药业	-10.74%	0.38%	5.4分
114	誉衡药业	-10.79%	5.15%	6.5分
115	西点药业	-11.02%	3.00%	5.4分
116	圣诺生物	-11.26%	3.11%	5.2分
117	金城医药	-11.59%	2.37%	5.4分
118	奥翔药业	-11.60%	-0.14%	4.5分
119	亨迪药业	-11.67%	3.71%	5.5分
120	拓新药业	-11.73%	2.94%	4.9分
121	-	-11.85%	6.69%	分
122	哈药股份	-12.04%	5.29%	6.4分
123	富士莱	-12.18%	3.97%	5.7分
124	亚虹医药	-12.20%	7.26%	5.2分
125	冀衡医药	-13.22%	3.57%	5.6分
126	-	-13.30%	2.35%	分
127	莎普爱思	-13.41%	0.59%	4.9分
128	必贝特	-13.41%	7.96%	5.6分
129	华仁药业	-13.42%	3.44%	5.9分
130	赛分科技	-13.44%	10.90%	6.4分
131	联环药业	-14.15%	2.37%	6.0分
132	中关村	-14.25%	2.94%	4.8分
133	广济药业	-14.42%	0.53%	5.4分
134	民生健康	-14.48%	-1.34%	5.9分
135	益方生物	-14.70%	7.47%	5.2分
136	新天地	-14.77%	0.57%	5.0分
137	罗欣药业	-15.21%	2.01%	5.9分
138	美诺华	-15.80%	8.29%	5.7分
139	宣泰医药	-15.96%	2.05%	4.2分
140	仟源医药	-16.00%	2.32%	5.4分
141	哈三联	-16.23%	3.42%	6.0分
142	多瑞医药	-16.25%	10.88%	5.7分
143	普洛药业	-16.44%	0.73%	6.2分
144	赛托生物	-17.37%	3.81%	5.0分
145	神奇制药	-17.47%	6.39%	5.8分
146	润都股份	-17.62%	1.76%	5.9分
147	汉商集团	-17.74%	1.40%	5.1分
148	*ST集友	-18.33%	-1.29%	4.1分
149	中哲精化	-18.35%	1.68%	5.6分
150	华特达因	-18.96%	5.05%	4.5分
151	津药药业	-18.99%	3.31%	5.6分
152	富祥股份	-19.21%	5.79%	6.2分
153	华北制药	-19.26%	3.21%	5.3分
154	石药创新	-20.05%	16.99%	6.0分
155	东亚药业	-20.27%	-1.59%	3.2分
156	键凯科技	-20.72%	6.75%	5.4分
157	灵康药业	-21.96%	8.86%	5.1分
158	宏辉果蔬	-23.34%	5.86%	5.0分
159	-	-	2.29%	分
160	联亚药业	-	0.00%	5.8分

<上一页 1 2 3 4 5...27 下一页>

行业评级

最近120个交易日，机构对该行业关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：4.8基本面打败了11%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（75分）

基本面得分最高的股票

[ 截止日期：2026-09-30 ]公司经营

盈利能力：很强，居行业前列，两项指标的行业排名分别为 54/217 ， 20/217。

[{"date":"2026-09-30","value":"5.79","vol":"-3.50"},{"date":"2026-06-30","value":"8.16","vol":"-0.06"},{"date":"2026-03-31","value":"3.79","vol":"0.46"},{"date":"2025-12-31","value":"18.54","vol":"-1.74"},{"date":"2025-09-30","value":"14.16","vol":"1.57"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
净资产收益率(%)	5.79	8.16	3.79	18.54	14.16
行业(%)	-3.50	-0.06	0.46	-1.74	1.57

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"77.82","vol":"49.55"},{"date":"2026-06-30","value":"82.43","vol":"49.07"},{"date":"2026-03-31","value":"81.87","vol":"50.10"},{"date":"2025-12-31","value":"85.11","vol":"49.45"},{"date":"2025-09-30","value":"84.44","vol":"49.28"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
销售毛利率(%)	77.82	82.43	81.87	85.11	84.44
行业(%)	49.55	49.07	50.10	49.45	49.28

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 148/217 ， 132/217。

[{"date":"2026-09-30","value":"-44.99","vol":"42.54"},{"date":"2026-06-30","value":"-27.52","vol":"19.66"},{"date":"2026-03-31","value":"-33.10","vol":"23.45"},{"date":"2025-12-31","value":"4.40","vol":"37.42"},{"date":"2025-09-30","value":"16.30","vol":"139.36"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
营业收入同比增长率(%)	-44.99	-27.52	-33.10	4.40	16.30
行业(%)	42.54	19.66	23.45	37.42	139.36

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"-61.65","vol":"151.58"},{"date":"2026-06-30","value":"-33.80","vol":"353.66"},{"date":"2026-03-31","value":"-39.36","vol":"48.30"},{"date":"2025-12-31","value":"3.78","vol":"-23.63"},{"date":"2025-09-30","value":"11.67","vol":"3.94"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
净利润同比增长率(%)	-61.65	-33.80	-39.36	3.78	11.67
行业(%)	151.58	353.66	48.30	-23.63	3.94

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，两项指标的行业排名分别为 110/217 ， 53/217。

[{"date":"2026-09-30","value":"0.20","vol":"0.31"},{"date":"2026-06-30","value":"0.19","vol":"0.21"},{"date":"2026-03-31","value":"0.08","vol":"0.10"},{"date":"2025-12-31","value":"0.45","vol":"0.41"},{"date":"2025-09-30","value":"0.33","vol":"0.30"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
总资产周转率(次)	0.20	0.19	0.08	0.45	0.33
行业(次)	0.31	0.21	0.10	0.41	0.30

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"2.05","vol":"1.93"},{"date":"2026-06-30","value":"1.68","vol":"1.30"},{"date":"2026-03-31","value":"0.85","vol":"0.65"},{"date":"2025-12-31","value":"4.45","vol":"2.59"},{"date":"2025-09-30","value":"3.46","vol":"1.94"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
存货增长率(次)	2.05	1.68	0.85	4.45	3.46
行业(次)	1.93	1.30	0.65	2.59	1.94

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-09-30","value":"-755.41","vol":"-0.17"},{"date":"2026-06-30","value":"-22.98","vol":"5.40"},{"date":"2026-03-31","value":"4.62","vol":"-2.46"},{"date":"2025-12-31","value":"50.58","vol":"15.68"},{"date":"2025-09-30","value":"64.89","vol":"4.82"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
现金流量净额/营业收入	-755.41	-22.98	4.62	50.58	64.89
行业	-0.17	5.40	-2.46	15.68	4.82

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"0.12","vol":"1.31"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.65","vol":"1.59"},{"date":"2025-09-30","value":"","vol":"0.00"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
资本支出／折旧和摊销	-	0.12	-	0.65	-
行业	0.00	1.31	0.00	1.59	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 146/217 ， 147/217。

[{"date":"2026-09-30","value":"13.03","vol":"3.64"},{"date":"2026-06-30","value":"10.43","vol":"3.68"},{"date":"2026-03-31","value":"12.06","vol":"3.65"},{"date":"2025-12-31","value":"6.58","vol":"3.44"},{"date":"2025-09-30","value":"7.12","vol":"3.52"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
流动比率	13.03	10.43	12.06	6.58	7.12
行业	3.64	3.68	3.65	3.44	3.52

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"11.81","vol":"2.95"},{"date":"2026-06-30","value":"9.84","vol":"2.98"},{"date":"2026-03-31","value":"11.55","vol":"3.01"},{"date":"2025-12-31","value":"6.37","vol":"2.82"},{"date":"2025-09-30","value":"6.79","vol":"2.78"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
速动比率	11.81	9.84	11.55	6.37	6.79
行业	2.95	2.98	3.01	2.82	2.78

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 144/217 ， 135/217。

[{"date":"2026-09-30","value":"7.51","vol":"32.63"},{"date":"2026-06-30","value":"8.78","vol":"33.24"},{"date":"2026-03-31","value":"7.95","vol":"32.97"},{"date":"2025-12-31","value":"12.95","vol":"34.15"},{"date":"2025-09-30","value":"11.99","vol":"33.59"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
资产负债率(%)	7.51	8.78	7.95	12.95	11.99
行业(%)	32.63	33.24	32.97	34.15	33.59

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"0.12","vol":"0.66"},{"date":"2026-06-30","value":"0.14","vol":"0.70"},{"date":"2026-03-31","value":"0.13","vol":"9.64"},{"date":"2025-12-31","value":"0.23","vol":"1.73"},{"date":"2025-09-30","value":"0.20","vol":"1.17"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
产权比率 (%)	0.12	0.14	0.13	0.23	0.20
行业(%)	0.66	0.70	9.64	1.73	1.17

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"5.27","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.85","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.16","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"5.35","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"6.01","blueLineValue":"2.56","type":"YC"}]

[华特达因]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]